Home LiteratureArticle Details
PMID: 1682818 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 343 ·No. 6 ·1991-06-00 ·Pages 623-32

Bültmann R, von Kügelgen I, Starke K

Abstract

The question of the existence of postjunctional, contraction-mediating alpha 2-adrenoceptors, in addition to the known alpha 1-adrenoceptors, was studied in the mouse isolated vas deferens. Both the alpha 1-selective agonist phenylephrine and the alpha 2-selective agonist 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline (UK 14,304) caused contraction of the vas deferens. In the presence of the alpha 1-selective antagonist prazosin (added in order to prevent an alpha 1 component in the effect of high concentrations of UK 14,304), the alpha 2-selective antagonist yohimbine and idazoxan shifted the concentration-response curve of UK 14,304 to the right in a manner compatible with competitive antagonism and with dissociation constants KB indicating the involvement of alpha 2-adrenoceptors. The maximal contraction elicited by UK 14,304 (in the presence of prazosin) was much lower than the maximal contraction elicited by phenylephrine. The effect of UK 14,304 was not changed by the P2-purinoceptor agonist alpha,beta-methylene-ATP and was reduced by neuropeptide Y, but was markedly enhanced by relatively low concentrations of phenylephrine. When the sympathetic fibres of the vas deferens were stimulated by trains of ten widely spaced (0.5 Hz) electric pulses, the tissue responded with ten separate twitches in which purinergic and adrenergic components were isolated by prazosin and suramin, respectively. Prazosin reduced the first adrenergic twitch in these trains at concentrations close to its KB value at alpha 1-adrenoceptors, whereas yohimbine and idazoxan reduced the first adrenergic twitch at concentrations far lower than their KB values at alpha 1-adrenoceptors.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Adenosine Triphosphate/analogs & derivatives,pharmacology Adrenergic alpha-Antagonists Animals Brimonidine Tartrate Dioxanes/pharmacology Drug Interactions Idazoxan Male Mice Muscle Contraction/drug effects Neuropeptide Y/metabolism Phenylephrine/pharmacology Prazosin/pharmacology Quinoxalines/antagonists & inhibitors,pharmacology Receptors, Adrenergic, alpha/drug effects,physiology Suramin/pharmacology Vas Deferens/drug effects,innervation,metabolism,physiology Yohimbine/antagonists & inhibitors,pharmacology
Chemicals
Adrenergic alpha-Antagonists Dioxanes Neuropeptide Y Quinoxalines Receptors, Adrenergic, alpha Phenylephrine Yohimbine Brimonidine Tartrate Suramin Adenosine Triphosphate alpha,beta-methyleneadenosine 5'-triphosphate Prazosin Idazoxan
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bültmann R
Pharmakologisches Institut, Freiburg, Federal Republic of Germany.
von Kügelgen I
Starke K
References (35)
35 references, click to expand
  1. Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype.
    J Pharmacol Exp Ther. 1989 Nov;251(2):640-4 PMID: 2553931
  2. Alpha 2-adrenoceptor-mediated responses to so-called selective alpha 1-adrenoceptor agonists after partial blockade of alpha 1-adrenoceptors.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):397-402 PMID: 2885759
  3. Partial agonist effect of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline (RX 781 094) at presynaptic alpha 2-adrenoceptors in rabbit ear artery.
    Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):75-8 PMID: 6138716
  4. The pharmacology of alpha 1- and alpha 2-adrenoceptors: evidence for and against a further subdivision.
    Pharmacol Ther. 1989;44(2):241-84 PMID: 2577511
  5. Some quantitative uses of drug antagonists.
    Br J Pharmacol Chemother. 1959 Mar;14(1):48-58 PMID: 13651579
  6. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors.
    J Pharmacol Exp Ther. 1985 Aug;234(2):350-7 PMID: 2991496
  7. Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery.
    Br J Pharmacol. 1989 Mar;96(3):539-46 PMID: 2566348
  8. Relative pre- and postjunctional roles of noradrenaline and adenosine 5'-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens.
    Neuroscience. 1985 Mar;14(3):929-46 PMID: 2859555
  9. Increase of [3H]clonidine binding sites induced by adenosine receptor agonists in rat vas deferens in vitro.
    Eur J Pharmacol. 1982 Dec 24;86(2):265-9 PMID: 6297934
  10. Simultaneous central administration of adrenaline and neuropeptide Y leads to antagonistic interactions in vasodepressor responses in awake male rats.
    Acta Physiol Scand. 1987 Jul;130(3):529-31 PMID: 2820197
  11. Hypothermia induces supersensitivity of mouse vas deferens to adrenergic agonists: evidence for postjunctional alpha 2-adrenoceptors.
    J Pharm Pharmacol. 1989 Jan;41(1):52-4 PMID: 2565966
  12. Alpha 2-adrenoceptor agonists potentiate responses mediated by alpha 1-adrenoceptors in the cat nictitating membrane.
    Br J Pharmacol. 1984 Oct;83(2):463-9 PMID: 6148985
  13. The influence of aging on alpha-adrenoceptors in rat heart and vas deferens.
    Jpn J Pharmacol. 1983 Feb;33(1):241-5 PMID: 6308316
  14. Alpha-adrenoceptors: a critical review.
    Med Res Rev. 1989 Oct-Dec;9(4):407-533 PMID: 2554078
  15. Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study.
    Neuroscience. 1986 May;18(1):151-66 PMID: 3755512
  16. Estimation of pA2 values at presynaptic alpha 2-autoreceptors in rabbit and rat brain cortex in the absence of autoinhibition.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):639-47 PMID: 2559334
  17. Effects of suramin and alpha, beta-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses.
    Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6 Pt 2):760-3 PMID: 2561308
  18. Reserpine and sympathetic denervation cause an increase of postsynaptic alpha 2-adrenoceptors.
    Eur J Pharmacol. 1982 May 7;80(1):105-8 PMID: 6284526
  19. Adrenergic and 'non-adrenergic' contributions to the two-component tetanus in the rat vas deferens.
    Eur J Pharmacol. 1987 Mar 17;135(2):173-82 PMID: 2884119
  20. Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons.
    Nature. 1990 Mar 1;344(6261):62-3 PMID: 1968229
  21. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.
    Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):55-78 PMID: 627
  22. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.
    Br J Pharmacol. 1988 Feb;93(2):243-5 PMID: 3359103
  23. UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes.
    Eur J Pharmacol. 1981 Jul 10;72(4):413-5 PMID: 6115759
  24. Precontraction-induced contractile response of isolated canine portal vein to alpha-2 adrenoceptor agonists.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):525-30 PMID: 2901046
  25. alpha-Adrenoceptors in the mouse vas deferens and their effects on its response to electrical stimulation.
    Br J Pharmacol. 1978 Jan;62(1):147-51 PMID: 23194
  26. Some statistical methods useful in circulation research.
    Circ Res. 1980 Jul;47(1):1-9 PMID: 7379260
  27. Effect of neuropeptide Y on alpha 2-adrenoceptor-mediated cardiovascular responses in the pithed rat.
    Br J Pharmacol. 1990 Aug;100(4):840-2 PMID: 2169943
  28. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries.
    Br J Pharmacol. 1986 Aug;88(4):767-77 PMID: 2427147
  29. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens.
    Br J Pharmacol. 1984 Aug;82(4):769-81 PMID: 6148114
  30. Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein.
    Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):33-6 PMID: 2864638
  31. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    J Pharm Pharmacol. 1978 May;30(5):312-3 PMID: 26747
  32. Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors.
    Br J Pharmacol. 1988 Oct;95(2):485-500 PMID: 2906557
  33. Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin.
    Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):328-34 PMID: 6138712
  34. Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens.
    Br J Pharmacol. 1983 Jun;79(2):379-93 PMID: 6317108
  35. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Naunyn Schmiedebergs Arch Pharmacol. 1984 Feb;325(2):136-44 PMID: 6144048
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1991-06-00
Pages
623-32
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com